BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10477010)

  • 1. High-dose-rate brachytherapy for early breast cancer: an ambulatory technique.
    Hennequin C; Durdux C; Espié M; Balla-Mekias S; Housset M; Marty M; Chotin G; Maylin C
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):85-90. PubMed ID: 10477010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment.
    Quéro L; Guillerm S; Taright N; Michaud S; Teixeira L; Cahen-Doidy L; Bourstyn E; Espié M; Hennequin C
    Radiother Oncol; 2017 Jan; 122(1):11-16. PubMed ID: 27474504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
    Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer.
    Guinot JL; Baixauli-Perez C; Soler P; Tortajada MI; Moreno A; Santos MA; Mut A; Gozalbo F; Arribas L
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):165-71. PubMed ID: 25446608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience.
    Arthur DW; Koo D; Zwicker RD; Tong S; Bear HD; Kaplan BJ; Kavanagh BD; Warwicke LA; Holdford D; Amir C; Archer KJ; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):681-9. PubMed ID: 12788173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.
    Fritz P; Berns C; Anton HW; Hensley F; Assman J; Flentje M; von Fournier D; Wannenmacher M
    Radiother Oncol; 1997 Oct; 45(1):23-32. PubMed ID: 9364628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer.
    Moreno F; Guedea F; Lopez Y; Ferrer F; Gutierrez C; Petriz L; Pera J
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):757-65. PubMed ID: 11020573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities.
    Perez CA
    Cancer J; 2003; 9(6):442-53. PubMed ID: 14740972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
    Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
    Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.
    Wazer DE; Berle L; Graham R; Chung M; Rothschild J; Graves T; Cady B; Ulin K; Ruthazer R; DiPetrillo TA
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):889-97. PubMed ID: 12095554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy.
    Baglan KL; Martinez AA; Frazier RC; Kini VR; Kestin LL; Chen PY; Edmundson G; Mele E; Jaffray D; Vicini FA
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1003-11. PubMed ID: 11429228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
    Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases.
    Deore SM; Sarin R; Dinshaw KA; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):601-6. PubMed ID: 8330988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.